
First Drug for Infant Brain Injury Gets $40M Boost
A groundbreaking treatment for brain injuries in newborns just secured $40 million to complete clinical trials, offering hope where no approved drugs currently exist. The therapy targets HIE, a condition that affects 1.2 million babies worldwide each year.





